Ethyleneoxynitazene
Jump to navigation
Jump to search
![]() | |
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C22H26N4O3 |
Molar mass | 394.475 g·mol−1 |
3D model (JSmol) | |
|
Ethyleneoxynitazene (Tetrahydrofuranitazene) is a benzimidazole derivative which has been sold as a designer drug over the internet and presumably has opioid effects. It is an analogue of etonitazene where the 4-ethoxy group attached to the benzyl ring has been cyclised round to the 3-position to form a 2,3-dihydrobenzofuran ring system. It was first reported in Estonia in February 2023,[1] and subsequently in the UK in late 2023.[2]
See also
- Etonitazepyne
- Etomethazene
- Isotonitazene
- Methylenedioxynitazene
- List of benzimidazole opioids
- Substituted benzofuran
References
- ^ "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
- ^ "Third addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids" (PDF). Advisory Council on the Misuse of Drugs. 15 December 2023.
Categories:
- Articles with short description
- Short description with empty Wikidata description
- Infobox drug articles with non-default infobox title
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Analgesics
- Designer drugs
- Benzimidazole opioids
- Aromatic ethers
- Diethylamino compounds
- Nitro compounds
- All stub articles
- Analgesic stubs